effects on beta-endorphm and alpha-MSH m the hypothalamus and caudal medulla PEPTIDES 9(4) 689-695, 1988.--Monosodmm glutamate (MSG) was given to neonatal male rats to determine its effects on neurons contmnlng beta-endorphm (B-END) and alpha-melanocyte stimulating hormone (a-MSH) within the basal hypothalamus (arcuate nucleus) and caudal medulla [nucleus tractus sohtarlus (NTS)I and on the levels of B-END and c~-MSH within these areas. Immunocytochemlcal studies demonstrated a reduction in the number of cells within the medial hypotbalamlc area (arcuate nucleus) among MSG-treated ammals versus saline controls. MSG did not reduce the number of cell bodies within the caudal medulla (NTS). MSG slgmficantly reduced B-END and a-MSH lmmunoreactive levels m the basal hypothalamus as determined by radmlmmunoassay. Whereas a slgmficant reduction in the level of B-END occurred in the ventral caudal medulla (VCM), none occurred in the dorsal caudal medulla (DCM) In contrast, levels of a-MSH increased slgmficantly m the DCM among animals receiving MSG compared to control animals. This study documents the contribution of beta-endorphm contmnmg neurons of the basal hypothalamus to areas of the caudal medulla. The effect of MSG on beta-endorphln and a-MSH neurons in these areas and their differentml effects on levels in the caudal medulla areas raises questmns about the sites of ongm of these pept~des.
PERIKARYA containing pro-opiomelanocortm (POMC) and its products, e.g., beta-endorphin (B-END) and alpha-MSH (a-MSH), are found in the arcuate nucleus and nucleus tractus solitarius (NTS) within the central nervous system [1, 9, 11] . B-END immunoreactive fibers are found in dorsal and ventral caudal medulla. Although the origin of these fibers is unknown, retrograde track tracing has demonstrated that cell bodies in the hypothalamus project to the NTS [19] . Radmimmunoassay studies in the adult rat, utihzlng either the entire caudal medulla or dorsal caudal medulla, indicate that the major POMC products are a-MSH and B-END [1, 2, 4] . Given the potential physiological actions of either a-MSH or B-END, it is important to discern not only their quantity but where these peptides may originate, i.e., the basal hypothalamus or the caudal medulla.
In the following study, monosodium glutamate (MSG) was administered to rats to assess the effects of MSG treatment on B-END and a-MSH in the caudal medulla and the basal hypothalamus. The administration of MSG during development has been demonstrated to result in loss of perikarya in the medial basal hypothalamus (arcuate nucleus) and a reduction in the B-END and a-MSH ammunoreactivity m the brain [5, 13] . The combinatmn of these approaches, radioimmunoassay and immunocytochemistry, were utihzed to discern the relationship of the visable reduction in the number of perikarya with reduced levels of B-END and a-MSH.
METHOD

Monosodtum Glutamate Treatment (MSG)
Monosodium glutamate (MSG) was administered intraperitoneally to cross-fostered male Sprague-Dawley rats at postnatal days 2, 4, 6 and 8. The dosage was 4 mg per gram body weight in a delivery volume of 100 microliters [14, 15] . The control httermates received 100 macroliters of 10% saline intraperitoneally at the same ages. Eaghteen (40%) of forty-five MSG-treated animals survived to adulthood with the highest death rate occurring between postnatal days 6 and 12. None of the control littermates died. Litters were housed in a twelve hour light-dark cycle (light from 0600 to 1800) with food and water provided ad lib. At postnatal day 21, the MSG and control rats were weaned and placed m maxed groups of six per cage.
Ti,saue Collection
The rats were housed in groups of up to six per cage until the ages of 95 and 105 days at which time they were killed by decapitation Six MSG and saline animals were randomly selected from these groups and served as the basis for the radiolmmunoassay studies. Following decapitation the brains were removed from the skull and regions were dissected immediately [6] . Upon dissection, the ports-medulla tissue block was frozen on dry Ice. The caudal medulla was dissected using the obex as the anterior boundary and the medulla-cord junction as the posterior boundary. The caudal medulla was then separated into ventral and dorsal regions using the central canal as the plane ot division The collected nssue was stored at -80°C Tissue extraction was performed as previously described [2] . The regions selected for study consisted of the hypothalamus, ventral medulla (VCM), and dorsal caudal medulla (DCM)
Radtolmmunoa~say oJ Beta-Endorphm and Alpha-MSH
The/3-END radlolmmunoassay (R1A) procedure was performed as previously described [3] . The assay consisted of a three-day dlsequlhbnum procedure using 4% sheep annrabbit globulin serum as the second antibody. The peptlde used as the standard and for lodlnatlon was human/ [3] The/3-END lmmunoreactivlty measured in the RIA was the sum total of/3-END, beta-hpotropln, and POMC lmmunoreactlvltles
The ~-MSH assay procedure was performed as previously described [2] The assay consisted of a five-day dlsequlhbnum procedure using 5% sheep anti-rabbit globulin serum as the second antibody. The peptlde used as the standard and for iodinatlon was c~-MSH (Cat No 7251, Peninsula Laboratories, Belmont, CA). The antlsera (Number 24) was donated by Dr. Thomas O'Donohue (formerly of Monsanto) The final dilution for antlsera was 1/30,000 The IC~ for the assay was 14.86_+0.61 femtomoles/ tube and the sensitivity was 4 0_+0.30 femtomoles/tube, The interassay coefficient of variation was 15 3% The c~-MSH antisera is 100% crossreactlve with c~-MSH, des-acetyl ~-MSH, and deaminated c~-MSH. The antiserum was 0 0% crossreactive with ACTH 1-24, human ACTH 1-39, human /3-END 61-91, human beta-llpotrophin and ACTH 1-10, ACTH 4-10 or ACTH 4-11 Protein levels were determined utilizing a standard procedure [12] . The Student's t-test for unpaired samples was used to assess the levels of significance between sample means
Colchlcme Pretreatment
To enhance the visualization of neuronal perikarya colchlclne (250/~g in 10/zl 0 ~ saline) was injected intracerebroventrlcularly into adult rats, MSG-or sahne-pretreated, from which brains were taken for ~mmunocytochemlstry. Only animals whose brains were used for lmmunocytochemistry were given colchlcine prior to sacnfice The main action of colchlclne is inhibition of mlcrotubule synthesis, resuiting in retardation of axonal transport and an accumulation of synthesized material m neuronal perlkarya [7] For inJection, each animal was anesthetized with sodmm pentobarbltal (5-10 mg per animal), the skull exposed, and colchlcine inJected into the right lateral ventricle. The skull opening was filled in with bone wax and the scalp closed using wound clips. Animals were allowed to recover for 48 hours, and then sacrificed as described below.
lmrnuno¢ ytochemt strv oJ Beta-Endorphm
Brain sections were prepared for lmmunocytochemlstry as described previously [10] Rats were anesthetized with sodium pentobarbltal (50 mg/kg) given lntraperltoneally and placed on crushed ice. The cardiovascular system was flushed with 0 9% sahne followed by perfuslon with ice-cold 4% formaldehyde (pH 7.4) In 0 1 M phosphate buffer, for 30 minutes. The brains were removed promptly and placed in the same fixanve for an additional hour, after which they were transferred into 15% sucrose in phosphate-buffered saline (PBS) and refrigerated overnight. Tissue blocks were frozen onto brass cryostat chucks with liquid nitrogen and sectioned in a cryostat at -20°C. Sections of 20/~m thickness were thaw-mounted onto gelatin-coated slides and stored at -80oc.
Primary rabbit antiserum to/3-END (gift of Dr. Stanley Watson, Mental Health Research Institute, University of Michigan) was diluted with 0.3% Triton X-100 in 0 02 M PBS, added onto the sections, and allowed first to incubate for 1 hour at 37°C, then overnight at 4°C After 3× 10 minutes PBS washes, the sections were incubated with goat antirabbit serum (Arnel) for 30 minutes at 37°C and then at 4°C overmght. The sections were again washed In PBS, and incubated m successive steps with horseradish peroxldase (HRP) antiserum, followed by another PBS wash, and HRP enzyme (Sigma, Type VI) for 40 minutes, each at 37°C The slides were then washed in PBS and immersed in a solution of 0.03% hydrogen peroxide and 0 125 mg/ml dxamlnobenZldlne (Sigma) for 15 minutes with constant stirring. The sections were washed in d~stllled water, bnefly osmlcated (2% osmium tetroxlde), washed, dehydrated through ethanols and xylenes and mounted in Permount Observations and photography were performed using a Leitz Orthoplan Microscope RESULTS Figure 1 shows the total body weights (grams) and whole brain wet weights (milligrams) of MSG and saline groups of animals The total body weights (mean_+SEM) of the animals receiving MSG (340_ + 14 grams) were significantly lower (p<0.005) than animals receiving sahne (419_+17 grams) Brain wet weights were also significantly lower (p <0 005) in the MSG-treated animals (1,740_+50 milligrams) compared to control animals (2,090_+40 milligrams). The pattern of the reduced brain wet weight in MSG animals was noted for the DCM and VCM, as well (Fig. 2) . The DCM showed a significant reduction (p <0.005), but a greater reduction was seen in the VCM with the values 29 25-+0.71 milligrams among saline control animals versus 19 38-+1 5 milligrams among the MSG animals (p<0 0001). There was no slgmficant The lmmunocytochemical study of B-END within the hypothalamus and caudal medulla of saline control versus MSG rats as presented in Fig. 3. In Fig. 3A , the presence of B-END staining cell bodies is apparent in the arcuate nucleus of saline control animals. In Fig 3B, the reduction m cell number in the medial basal hypothalamus (arcuate nucleus) is prominent. Of note is the increase in size of perikarya contained within the lateral basal bypothalamlc area. In comparison, the number of cell bodies within the caudal medulla were not reduced among MSG-treated animals versus saline control, nor did there appear to be an alteration in the size of the cell bodies, as was noted in the lateral hypothalamic B-END containing cells (Fig. 3C and D) . The lack of a decrease in the levels of fl-END ~m-munoreactiwty in the DCM would support the lack of a decrease in cell number in the nucleus tractus solitarlus as demonstrated by ~mmunocytochemlstry. If all the material w~thin the VCM originated from the DCM, e g, nucleus tractus sohtarius cell bodies, one would expect that the levels of/3-END in the VCM in MSG-treated versus control ammals would not decrease, as well. The finding of a sigmficant drop m/3-END levels within the VCM suggests that this materml originates from an additional site other than the dorsal caudal medulla, such as the arcuate nucleus. With cardiovascular and respiratory centers present in VCM areas, the hypothalamus could modulate physiological functtomng ongmatmg from these areas via these projections. Such "distant" versus "proximal" mnervatlons would allow subtle but zmportant modulations Whde alteraUons in the levels of a-MSH immunoreactiv~ty in the hypothalamus paralleled those seen w~th fl-END, alterations w~thin the caudal medulla were quite different. Among MSG-treated animals, a drop in c~-MSH levels comparable to /3-END levels m VCM was not noted. In fact, a-MSH levels m the VCM remained unchanged, while a-MSH levels m the DCM rose s~gmficantly. One can only speculate as to why the alterations in a-MSH levels are different than those offl-END. Two speculations are: First, the distribution of end products of pro-oplomelanocortm (POMC)-contammg cells within the dorsal caudal medulla (nucleus tractus solitarius) may be regionally specific. This same logic may also apply to material originating from outside the dorsal caudal medulla, i.e., the arcuate nucleus or possibly other areas of the brain. Thts might explain on an anatomical basis why there are differences in levels fol- lowing the lesloning of the medial hypothalamus Second, on a biochemical basts, the differences may be due to an alteration in the rates of metabolism, either in production or in breakdown.
The alterations in the levels of c~-MSH are further complicated by the identification of the alpha-2 group within the lateral hypothalamlc area [9, 16] These cell bodies have been identiffed as being a separate group which contain c~-MSH, yet no other POMC-derlved material [20] . Studies have suggested that this cell group contains c~-MSH-hke material, not "true" a-MSH [9] The imphcatlon of this finding is that the a-MSH identified within the caudal medulla, both DCM and VCM, may represent a combination of POMC-derived a-MSH, originating from the dorsal caudal medulla (NTS) and the medial basal hypothalamus (arcuate nucleus), and an a-MSH-hke materml originating from the alpha-2 cell group within the lateral hypothalamus Although these explanations might explam steady state levels of a-MSH in MSG-lesxoned animals or a differential decrease, as was found with/3-END, there remains the question of why a-MSH levels increased in DCM among MSGtreated animals versus control animals Any explanation is flawed by the lack of knowledge of the site of origin of the c~-MSH lmmunoreactlve material, whether "true ~-MSH" or "c~-MSH-like." Nevertheless, there are two explanattons that can be put forth to explain why post MSG levels ot c~-MSH increased" (1) The increase represents the impact of the earher lesion, yet does not reflect current need; and (2) The increase is reflective of an increased need of a-MSH for the current homeostasis of the system. In regard to the first explanation, a-MSH has been reported to be atrophic agent in the brain [8, 17, 18] . Cells within the dorsal caudal medulla (NTS) responsible for the modulation of respiratory and cardiovascular functioning, might be influenced by the trophlc action(s) of a-MSH during development. Therefore, increased levels of a-MSH in the DCM could be explained on the basis of the importance of these cells receiving exposure to c~-MSH during development. Multiple sites, i.e., medial and lateral hypothalamus, and medulla, as well as the alpha-2 cell group within the lateral hypothalamus, could represent a built-in redundancy constituting a fail safe system, which would ensure that c~-MSH or an c~-MSH-11ke material reach the nucleus tractus sohtarlus neurons during development. Such an alteration resulting from a lesion of other primary s~tes may remain throughout the life of the animal. Further studies are obwously needed to determine the anatomy and biochemistry of these peptldes and their roles during development and m the physiological functioning of the adult
In conclusion, future studies of/3-END material w~thln the caudal medulla, especially studies which attempt to characterize/3-END forms in this area, must take into account the significant contribution of medial basal hypothalamlc POMC-containing neurons to the levels of/3-END m this area. Since this study was not designed to determine the origins of the projections to these areas nor to differentiate a-MSH from c~-MSH-like material, the hypotheses concernlng the alterations in the levels of a-MSH are based on hmlted information Further studies of the a-MSH cells and medml basal hypothalmlc POMC-containmg neurons are needed to clarify the role of these cell groups during development, l.e, do they produce a "trophlc" material necessary for the development of caudal medulla neurons, and to determine their b~ochemical composition and role as phys~ologlcal modulators m the adult
